Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.

Martin, Miguel

Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial. [electronic resource] - Breast cancer research : BCR Apr 2014 - R38 p. digital

Publication Type: Journal Article; Validation Study

1465-542X

10.1186/bcr3642 doi


Antineoplastic Agents, Hormonal--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Clinical Trials, Phase III as Topic
Cyclophosphamide--administration & dosage
Epirubicin--administration & dosage
Female
Fluorouracil--administration & dosage
Humans
Lymphatic Metastasis
Multicenter Studies as Topic
Outcome Assessment, Health Care--methods
Paclitaxel--administration & dosage
Prospective Studies
Randomized Controlled Trials as Topic
Receptor, ErbB-2--metabolism
Receptors, Estrogen--metabolism
Reproducibility of Results
Retrospective Studies